Join Quotient Sciences' Vice President of Pharmaceutical Sciences (Philadelphia), Dr Chinmay Maheshwari, Vice President of Pharmaceutical Sciences (Nottingham), Dr Andy Lewis, and Senior Research Fellow, Dr Aruna Railkar at the Formulation & Delivery Series US from September 29-30, 2020. Aruna and Chinamy will be on hand to discuss Quotient's drug development and manufacturing capabilities and to learn more about your project specific needs, so schedule a 1:1 partnering meeting with them today!
Dr Andy Lewis will be presenting at the event and will be part of the Small Molecule Drug Formulation stream on Day 2 - Stream 1 at 10:30am PDT.
Presentation Title: Developing an Oral Modified Release (MR) Formulation - Challenges and Considerations for Achieving Success
Presenter: Dr Andy Lewis, Vice President of Pharmaceutical Sciences
Dr Andy Lewis is the Vice President of Pharmaceutical Sciences at Quotient SciencesAndy has over 16 years’ experience in the pharmaceutical and drug delivery industry. He currently leads a team of 120 scientists working on formulation development, clinical manufacturing and pharmaceutical analysis projects. Dr Lewis is dedicated to overcoming drug delivery challenges, including solubility enhancement, controlled release and transmucosal delivery of proteins and peptides. He is a member of the Academy of Pharmaceutical Scientists of Great Britain, and is currently Secretary of the Controlled Release Society.
To schedule a meeting with Andy, click here.
Formulation Expert Bios
Dr Chinmay Maheshwari- Vice President, Pharmaceutical Sciences
Chinmay Maheshwari, Ph.D. is the VP of Pharmaceutical Sciences at Quotient Sciences, Philadelphia. Some of his responsibilities include: management of product development, analytical sciences, site operations and technical project management. He has 20 years of experience in various stages of pharmaceutical development such as preformulation, solid dosage formulation, new technology development, sterile product development, biopharmaceutics and modeling and simulation. Chinmay received his Ph.D. in Pharmaceutical Sciences from the University of Michigan, Ann Arbor.
To schedule a meeting with Chinmay, click here.
Dr Aruna Railkar- Senior Research Fellow at Quotient Sciences
Aruna has over 25 years of experience in the pharmaceutical industry working at the discovery – development interface, providing critical input for progressing compounds into clinical development, prodrug evaluation, understanding challenges in absorption/exposure of lead molecules and development of formulation strategies (conventional or enabling) based on compound properties. During her career at Hoffmann-La Roche, she led the group characterizing the physicochemical and biopharmaceutic properties of compounds to inform NCE selection and provided stage appropriate formulation development for preclinical and clinical studies collaborating with discovery and development teams in multiple therapeutic areas. Her recent experience also covers clinical formulation development of poorly soluble molecules using amorphous or lipid based formulations, oral and injectable controlled release dosage forms. Her area of interest is the development of novel or improved dosage forms for existing drugs (as an alternate route of administration or improved delivery which can use the 505(b)(2) development pathway). Aruna completed her Ph. D in Pharmaceutical sciences from West Virginia University and postdoc at the University of Minnesota. She joined Quotient Sciences in the Scientific consulting group and supports the Business Development team in designing and scoping the studies for clients and assists in scientific and technical discussions with project teams.
To schedule a meeting with Aruna, click here.
When: Tuesday, September 29-30
Event Website: https://www.oxfordglobal.co.uk/formulation-delivery-series-us-virtual/